Cargando…
Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
Epithelial ovarian carcinoma (EOC) is an aggressive tumor often diagnosed at an advanced stage, when there is little or no prospect of cure. Despite advances in surgical and chemotherapeutic strategies, only marginal improvements in patient outcome have been obtained. Hence, unraveling the biologica...
Autores principales: | Morone, Simona, Lo-Buono, Nicola, Parrotta, Rossella, Giacomino, Alice, Nacci, Giulia, Brusco, Alfredo, Larionov, Alexey, Ostano, Paola, Mello-Grand, Maurizia, Chiorino, Giovanna, Ortolan, Erika, Funaro, Ada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423388/ https://www.ncbi.nlm.nih.gov/pubmed/22916288 http://dx.doi.org/10.1371/journal.pone.0043649 |
Ejemplares similares
-
Human canonical CD157/Bst1 is an alternatively spliced isoform masking a previously unidentified primate-specific exon included in a novel transcript
por: Ferrero, Enza, et al.
Publicado: (2017) -
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
por: Ortolan, Erika, et al.
Publicado: (2014) -
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma
por: Augeri, Stefania, et al.
Publicado: (2018) -
Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer
por: Lefort, Karine, et al.
Publicado: (2016) -
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
por: Ostano, Paola, et al.
Publicado: (2020)